Clinical trial
Pharmacogenetics of Disulfiram for Cocaine
NCT00149630 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00149630 |
|---|---|
| Title | Pharmacogenetics of Disulfiram for Cocaine |
| Official title | Effectiveness of Disulfiram for Treating Cocaine Dependence in Individuals With Different Dopamine Beta Hydroxylase (DBH) Genes |
| Acronym | Disulfiram |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH Yale University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine Dependence, Opioid Dependence |
| Intervention type | Behavioral, Drug, Other |
| Interventions | Disulfiram, Methadone, CBT, Lactose |
| Enrollment | 93 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 8, 2005 |
| Last update posted | Mar 15, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: